Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

Quarterly rpt on consolidated results for the financial period ended 30/9/2005

PHARMANIAGA BERHAD

Quarterly report for the financial period ended

30/09/2005
Quarter3
Financial Year End31/12/2005
The figureshave not been audited

Attachments

pharma_klse0509_final.doc
803 KB

SUMMARY OF KEY FINANCIAL INFORMATION
30/09/2005


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR CORRESPONDING PERIOD
30/09/2005 
30/09/2004 
30/09/2005 
30/09/2004 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
221,566
229,265
692,222
599,214
2Profit/(loss) before tax
8,854
22,581
41,415
59,514
3Profit/(loss)
after tax and minority
interest
6,480
14,201
25,890
37,467
4Net profit/(loss) for
the period
6,480
14,201
25,890
37,467
5Basic earnings/(loss) per share (sen)
6.23
13.99
25.19
37.06
6Dividend per share (sen)
0.00
0.00
0.00
4.50



AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR
END
7Net tangible assets per share (RM)

2.6500
2.6000

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :
For the current financial period ended 30 September 2005, the Board of Directors is recommending an interim tax exempt dividend of 3.5 sen per share (2004:interim tax exempt dividend of 4.5 sen on 101,606,267 ordinary shares of RM1.00 each amounting to RM4,572,282 was paid on 19 October 2004). The date of book closure will be announced in due course.


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced22 Nov 2005  
CategoryFinancial Results
Reference NoCC-051116-37552